Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study

Authors

Joel S. Perlmutter, Washington University School of Medicine in St. Louis
Stacey Barton, Washington University School of Medicine in St. Louis
Shineeka Kaye Smith, Washington University School of Medicine in St. Louis
et alFollow

Journal

Frontiers in Aging Neuroscience

Publication Date

2014

Volume

6

Issue

April

Inclusive Pages

Article Number 78

Document Type

Open Access Publication

DOI

10.3389/fnagi.2014.00078

Rights and Permissions

Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross CA, Williams JK ,Nance MA, Erwin CJ, Westervelt HJ, Harrington DL, Bockholt HJ, Zhang Y, McCusker EA, Chiu EM, Panegyres PK and PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2014). Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study. Frontiers in Aging Neuroscience, 6:78. doi:10.3389/fnagi.2014.00078

Recommended Citation

Perlmutter, Joel S.; Barton, Stacey; Smith, Shineeka Kaye; and et al, "Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study." Frontiers in Aging Neuroscience. 6, April. Article Number 78. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/2950